Addressing Illicit Drug Addiction: The Role of Methadone, Buprenorphine, and Naltrexone

Feb 14


Kalyani Rajalingham

Kalyani Rajalingham

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Illicit drug addiction is a pervasive issue with far-reaching consequences, impacting millions globally. Among the treatment options, methadone, buprenorphine, and naltrexone stand out as medications with demonstrated effectiveness. This article delves into the pharmacological aspects, usage guidelines, and comparative efficacy of these anti-addiction drugs, providing insights into their roles in combating substance dependence.

The Global Challenge of Illicit Drug Addiction

Illicit drug addiction is a significant public health concern,Addressing Illicit Drug Addiction: The Role of Methadone, Buprenorphine, and Naltrexone Articles with the National Institute on Drug Abuse reporting that in 2020, approximately 13.5% of Americans aged 12 or older had used an illicit drug in the past month [1]. Cannabis remains the most widely used illicit substance, with an estimated 49.6 million past-year users in the United States in 2020 [2]. Illicit drug use is associated with a range of health risks, including the transmission of infectious diseases, mental health disorders, and the potential for overdose and death. In 2019, over 70,000 drug overdose deaths occurred in the United States, highlighting the urgent need for effective treatment interventions [3].

Methadone: A Staple in Opioid Dependence Treatment

Methadone, a full µ-opiate-receptor agonist, is a cornerstone in the treatment of opioid dependence. It mitigates withdrawal symptoms and reduces cravings, facilitating recovery and reducing the risk of relapse. The Substance Abuse and Mental Health Services Administration (SAMHSA) recommends methadone doses of 80-125 mg per day for optimal outcomes in opioid treatment programs [4]. However, methadone is not without risks; it can cause respiratory depression and has a potential for misuse. Careful monitoring and adherence to guidelines are crucial to minimize adverse effects and prevent overdose.

Buprenorphine: Expanding Access to Treatment

Buprenorphine, a partial µ-opiate-receptor agonist, offers a safer alternative to methadone with a lower risk of respiratory depression. It is often combined with naloxone to deter misuse. According to the World Health Organization, buprenorphine is effective for both detoxification and maintenance treatment of opioid dependence [5]. Its unique pharmacological profile allows for flexible dosing and administration, making it a valuable option for outpatient settings and increasing access to treatment for those in need.

Naltrexone: A Non-Opioid Option for Sustaining Recovery

Naltrexone, an opioid receptor antagonist, blocks the euphoric effects of opioids and reduces cravings. It is available in oral and extended-release injectable forms, the latter of which can provide coverage for up to one month. Naltrexone is particularly useful for individuals who have completed detoxification and are motivated to remain abstinent. The Centers for Disease Control and Prevention (CDC) notes that extended-release naltrexone is as effective as other medications for opioid use disorder when patients are able to initiate treatment [6].

Conclusion: A Multifaceted Approach to Treatment

The battle against illicit drug addiction requires a multifaceted approach, with methadone, buprenorphine, and naltrexone playing pivotal roles. Each medication has its own set of advantages and considerations, and the choice of treatment should be tailored to the individual's needs and circumstances. Ongoing research and policy efforts are essential to improve access to these life-saving treatments and to continue advancing the field of addiction medicine.


  1. National Institute on Drug Abuse. "DrugFacts: Nationwide Trends." [Internet]. 2021 [cited 2023-04-01]. Available from:
  2. Substance Abuse and Mental Health Services Administration. "Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health." [Internet]. 2021 [cited 2023-04-01]. Available from:
  3. Centers for Disease Control and Prevention. "Drug Overdose Deaths in the U.S. Top 100,000 Annually." [Internet]. 2021 [cited 2023-04-01]. Available from:
  4. Substance Abuse and Mental Health Services Administration. "Methadone." [Internet]. 2021 [cited 2023-04-01]. Available from:
  5. World Health Organization. "Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence." [Internet]. 2009 [cited 2023-04-01]. Available from:
  6. Centers for Disease Control and Prevention. "Medication-Assisted Treatment for Opioid Use Disorder Study (MAT Study)." [Internet]. 2021 [cited 2023-04-01]. Available from: